Fibro Daily

Arthritis in Kids Eased by IL-6 Blocker

Fibro Daily April 26, 2013

Among patients with polyarticular subtype of juvenile idiopathic arthritis (JIA that received treatment with tocilizumab (Actemra, there was a noticeable and prolonged response.

The ages of the study ranged form 2 to 17 spanning 188 patients.

Still, more studies are need to determine who can benefit the most from this treatment.

Read more:

IL-6 Blocker Eases Arthritis in Kids



Powered by Facebook Comments

Tagged with:

Comments are closed.

Login to your account

Can't remember your Password ?

Register for this site!